The Europe medical gloves market, valued at USD 4.35 billion in 2024, is set to grow steadily, reaching USD 7.89 billion by 2033. As healthcare demands rise, so does the reliance on medical gloves—a critical component in infection control. However, environmental concerns loom large over this b
As the landscape of biopharmaceutical manufacturing undergoes significant changes, Danaher Corporation stands at a pivotal crossroads with the potential to lead through its innovative strategies and products. At the TD Cowen Health Care Conference, Danaher President and CEO Rainer Blair emphasized
Repligen, an innovative leader in bioprocess technology, has made a strategic move by acquiring essential upstream Process Analytical Technology (PAT) assets from 908 Devices for a total of $70 million. This acquisition should be viewed as more than just a simple addition of technology; it
The Contract Development and Manufacturing Organization (CDMO) sector is navigating a landscape marked by significant changes and evolving trends. Gil Roth, President of the Pharma & Biopharma Outsourcing Association, provides a comprehensive analysis of the sector's current state and
In the rapidly evolving landscape of biopharmaceutical manufacturing, capturing real-time data has become pivotal in optimizing bioreactor performance and producing high-quality products. Inline monitoring technologies are at the forefront of this transformation, offering real-time surveillance and
In recent years, the healthcare industry has experienced a paradigm shift due to the rapid advancement of telemedicine technologies and the strategic investments made by pharmaceutical, medical device, and digital therapeutics (DTx) companies. The surge in telehealth investments is primarily driven
